Ibandronate sodium
NDC 50090-7654, Ibandronate sodium, tablet, from A-S Medication Solutions.
- Product NDC
- 50090-7654
- Status
- Listed
- Labeler
- A-S Medication Solutions
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078997
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50090-7654 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IBANDRONATE SODIUM150 mg/1
Pharmacologic classes
Bisphosphonate [EPC]; Diphosphonates [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50090-7654-0 | 50090765400 | 1 BLISTER PACK in 1 CARTON (50090-7654-0) / 3 TABLET in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e5b6c2a9-a55f-41f9-a592-e26ef03e2d73
Use it
Look up 50090-7654 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50090-7654 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50090-7654. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.